← FDA Drug Approvals (Drugs@FDA)

ABACAVIR SULFATE; LAMIVUDINE

NDA · New Drug Application · Sponsor: AUROBINDO PHARMA LTD · Approved 2008-12-19

Drug application

FDA Application #

NDA022295

Application type

New Drug Application

Brand name

ABACAVIR SULFATE; LAMIVUDINE

Generic name

Abacavir Sulfate

Active ingredients

ABACAVIR SULFATE; LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

AUROBINDO PHARMA LTD

First approval

2008-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown